ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 3,100.00
+585.00 (23.26%)
At close: Apr 3, 2026
ADBiotech Revenue
In the year 2025, ADBiotech had annual revenue of 12.90B KRW with 15.81% growth. ADBiotech had revenue of 2.97B in the quarter ending December 31, 2025, a decrease of -36.01%.
Revenue
12.90B
Revenue Growth
+15.81%
P/S Ratio
4.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.90B | 1.76B | 15.81% |
| Dec 31, 2024 | 11.14B | 664.30M | 6.34% |
| Dec 31, 2023 | 10.47B | -159.63M | -1.50% |
| Dec 31, 2022 | 10.63B | -1.21B | -10.21% |
| Dec 31, 2021 | 11.84B | 2.02B | 20.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| J2KBIO | 32.97B |
| Naturalendo Tech | 22.23B |
| Ark Solutions | 16.08B |
| PanGen Biotech | 13.42B |
| HLB Pep | 4.96B |
| EyeGene | 3.57B |
| SunBio,Inc. | 2.17B |
| Aptamer Sciences | 1.08B |